Subscribe To
Recursion: recursion os technology has potential to revolutionize biological drug discovery
Recursion Pharma is hoping to revolutionize drug discovery with its Recursion OS technology; potential to improve drug discovery and processing capabi...
December 28, 2021, 9:28 pm
Recursion: recursion os technology has potential to revolutionize biological drug discovery
Recursion Pharma is hoping to revolutionize drug discovery with its Recursion OS technology; potential to improve drug discovery and processing capabi...
December 28, 2021, 9:28 pm
Recursion: recursion os technology has potential to revolutionize biological drug discovery
Recursion Pharma is hoping to revolutionize drug discovery with its Recursion OS technology; potential to improve drug discovery and processing capabi...
December 28, 2021, 9:28 pm
Veteran strategist david roche says china is set to ease monetary policy further
Monetary policy in China is set to ease as the government focuses on stability and "common prosperity," veteran investment strategist David ...
December 28, 2021, 12:06 am
Veteran strategist david roche says china is set to ease monetary policy further
Monetary policy in China is set to ease as the government focuses on stability and "common prosperity," veteran investment strategist David ...
December 28, 2021, 12:06 am
Veteran strategist david roche says china is set to ease monetary policy further
Monetary policy in China is set to ease as the government focuses on stability and "common prosperity," veteran investment strategist David ...
December 28, 2021, 12:06 am
Diversify, diversify - concentration risks of several pharma companies
roche is optimally diversified both in terms of geography and in terms of portfolio. Pfizer and Eli Lil...
December 5, 2021, 9:43 am
Diversify, diversify - concentration risks of several pharma companies
roche is optimally diversified both in terms of geography and in terms of portfolio. Pfizer and Eli Lil...
December 5, 2021, 9:43 am
Diversify, diversify - concentration risks of several pharma companies
roche is optimally diversified both in terms of geography and in terms of portfolio. Pfizer and Eli Lil...
December 5, 2021, 9:43 am
Shell builds singapore pyrolysis oil unit to convert plastic waste to chemicals
Royal Dutch Shell said on Tuesday it plans to build a pyrolysis oil upgrader to turn plastic waste into chemical feedstock at its petrochemical comple...
November 23, 2021, 12:18 am
Shell builds singapore pyrolysis oil unit to convert plastic waste to chemicals
Royal Dutch Shell said on Tuesday it plans to build a pyrolysis oil upgrader to turn plastic waste into chemical feedstock at its petrochemical comple...
November 23, 2021, 12:18 am
Shell builds singapore pyrolysis oil unit to convert plastic waste to chemicals
Royal Dutch Shell said on Tuesday it plans to build a pyrolysis oil upgrader to turn plastic waste into chemical feedstock at its petrochemical comple...
November 23, 2021, 12:18 am
Novartis will sell back its roche stake for $21 billion. both stocks are rising.
A roche shareholder since 2001, Novartis expects to report a gain of $14 billion from the stake sale, w...
November 4, 2021, 5:32 am
Novartis will sell back its roche stake for $21 billion. both stocks are rising.
A roche shareholder since 2001, Novartis expects to report a gain of $14 billion from the stake sale, w...
November 4, 2021, 5:32 am
Novartis will sell back its roche stake for $21 billion. both stocks are rising.
A roche shareholder since 2001, Novartis expects to report a gain of $14 billion from the stake sale, w...
November 4, 2021, 5:32 am
Sarepta therapeutics' srp-9001 shows sustained functional improvements in multiple studies of patients with duchenne
CAMBRIDGE, Mass., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseas...
October 11, 2021, 9:13 am
Sarepta therapeutics' srp-9001 shows sustained functional improvements in multiple studies of patients with duchenne
CAMBRIDGE, Mass., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseas...
October 11, 2021, 9:13 am
Sarepta therapeutics' srp-9001 shows sustained functional improvements in multiple studies of patients with duchenne
CAMBRIDGE, Mass., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseas...
October 11, 2021, 9:13 am
Morphosys' licensing partner roche received breakthrough therapy designation for gantenerumab in alzheimer's disease
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / October 11, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announced today that its licensing partner ...
October 11, 2021, 3:10 am
Morphosys' licensing partner roche received breakthrough therapy designation for gantenerumab in alzheimer's disease
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / October 11, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announced today that its licensing partner ...
October 11, 2021, 3:10 am